Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECIDE-CRLM-10: Localized Treatment for Colorectal Liver Metastases
NCT06208371Phase 3Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2024
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Five-year survival rate at 5 years. Started Jan 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06208371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06208371.